Latest Insider Transactions at Phreesia, Inc. (PHR)
This section provides a real-time view of insider transactions for Phreesia, Inc. (PHR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Phreesia, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Phreesia, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 15
2021
|
David Linetsky SVP, Life Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
5,452
+3.6%
|
$21,808
$4.71 P/Share
|
|
Oct 01
2021
|
Ramin Sayar Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,797
+39.66%
|
-
|
|
Sep 01
2021
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
4,978
-1.15%
|
$348,460
$70.56 P/Share
|
|
Sep 01
2021
|
David Linetsky SVP, Life Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
4,978
+3.31%
|
$19,912
$4.71 P/Share
|
|
Aug 31
2021
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
474
-0.34%
|
$33,654
$71.84 P/Share
|
|
Aug 31
2021
|
David Linetsky SVP, Life Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
474
+0.34%
|
$1,896
$4.71 P/Share
|
|
Aug 30
2021
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
54,672
-1.41%
|
$3,881,712
$71.71 P/Share
|
|
Aug 30
2021
|
Chaim Indig Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
54,672
+2.08%
|
$328,032
$6.37 P/Share
|
|
Aug 27
2021
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
57,556
-1.11%
|
$4,086,476
$71.92 P/Share
|
|
Aug 27
2021
|
Chaim Indig Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
57,556
+4.22%
|
$230,224
$4.71 P/Share
|
|
Aug 27
2021
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
21,455
-3.45%
|
$1,523,305
$71.89 P/Share
|
|
Aug 27
2021
|
David Linetsky SVP, Life Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
21,455
+11.71%
|
$42,910
$2.55 P/Share
|
|
Aug 26
2021
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
800
-0.06%
|
$56,000
$70.05 P/Share
|
|
Aug 26
2021
|
Chaim Indig Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
800
+0.06%
|
$3,200
$4.71 P/Share
|
|
Aug 26
2021
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
800
-0.57%
|
$56,000
$70.07 P/Share
|
|
Aug 26
2021
|
David Linetsky SVP, Life Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
800
+0.56%
|
$1,600
$2.55 P/Share
|
|
Aug 25
2021
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
600
-0.05%
|
$42,000
$70.03 P/Share
|
|
Aug 25
2021
|
Chaim Indig Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
600
+0.05%
|
$2,400
$4.71 P/Share
|
|
Aug 25
2021
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
500
-0.35%
|
$35,000
$70.04 P/Share
|
|
Aug 25
2021
|
David Linetsky SVP, Life Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+0.35%
|
$1,000
$2.55 P/Share
|
|
Aug 25
2021
|
Allison C Hoffman General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
2,082
-2.48%
|
$143,658
$69.05 P/Share
|
|
Aug 24
2021
|
Allison C Hoffman General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,577
-2.98%
|
$177,813
$69.54 P/Share
|
|
Aug 06
2021
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,660
-0.13%
|
$116,200
$70.53 P/Share
|
|
Aug 06
2021
|
Chaim Indig Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,660
+0.13%
|
$6,640
$4.71 P/Share
|
|
Aug 05
2021
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
28,120
-2.2%
|
$1,968,400
$70.27 P/Share
|
|
Aug 05
2021
|
Chaim Indig Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
28,120
+2.16%
|
$112,480
$4.71 P/Share
|
|
Aug 05
2021
|
Michael Weintraub Director |
SELL
Open market or private sale
|
Direct |
8,236
-4.7%
|
$576,520
$70.13 P/Share
|
|
Aug 05
2021
|
Michael Weintraub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,236
+4.49%
|
$16,472
$2.03 P/Share
|
|
Aug 05
2021
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
5,273
-3.14%
|
$363,837
$69.72 P/Share
|
|
Jul 30
2021
|
Edward L Cahill Director |
BUY
Grant, award, or other acquisition
|
Direct |
128
+0.45%
|
$8,704
$68.35 P/Share
|
|
Jul 30
2021
|
Lainie Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
128
+0.89%
|
$8,704
$68.35 P/Share
|
|
Jul 30
2021
|
Michael Weintraub Director |
SELL
Open market or private sale
|
Direct |
10
-0.01%
|
$700
$70.0 P/Share
|
|
Jul 30
2021
|
Michael Weintraub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10
+0.01%
|
$20
$2.03 P/Share
|
|
Jul 30
2021
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
102
-0.01%
|
$7,140
$70.0 P/Share
|
|
Jul 30
2021
|
Chaim Indig Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
102
+0.01%
|
$408
$4.71 P/Share
|
|
Jul 29
2021
|
Michael Weintraub Director |
SELL
Open market or private sale
|
Direct |
1,754
-1.04%
|
$122,780
$70.02 P/Share
|
|
Jul 29
2021
|
Michael Weintraub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,754
+1.03%
|
$3,508
$2.03 P/Share
|
|
Jul 29
2021
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
6,779
-0.54%
|
$474,530
$70.03 P/Share
|
|
Jul 29
2021
|
Chaim Indig Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,779
+0.27%
|
$20,337
$3.37 P/Share
|
|
Jul 21
2021
|
Michael Weintraub Director |
SELL
Open market or private sale
|
Direct |
2,500
-1.47%
|
$162,500
$65.15 P/Share
|
|
Jul 21
2021
|
Michael Weintraub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+1.45%
|
$5,000
$2.03 P/Share
|
|
Jul 20
2021
|
Michael Weintraub Director |
SELL
Open market or private sale
|
Direct |
7,500
-4.3%
|
$487,500
$65.08 P/Share
|
|
Jul 20
2021
|
Michael Weintraub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+4.12%
|
$15,000
$2.03 P/Share
|
|
Jul 16
2021
|
Michael Weintraub Director |
SELL
Open market or private sale
|
Direct |
20,000
-5.48%
|
$1,260,000
$63.89 P/Share
|
|
Jul 16
2021
|
Michael Weintraub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+9.66%
|
$40,000
$2.03 P/Share
|
|
Jul 08
2021
|
Edward L Cahill Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,605
+8.38%
|
-
|
|
Jul 08
2021
|
Lainie Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,605
+15.63%
|
-
|
|
Jul 08
2021
|
Gillian Munson Director |
SELL
Open market or private sale
|
Direct |
3,055
-6.83%
|
$192,465
$63.46 P/Share
|
|
Jul 08
2021
|
Gillian Munson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,605
+10.18%
|
-
|
|
Jul 08
2021
|
Cheryl Pegus |
BUY
Grant, award, or other acquisition
|
Direct |
2,605
+14.13%
|
-
|